Issue link: https://www.e-digitaleditions.com/i/1544305
Inhalation April 2026 23 ing the language of flow control to the practical word "choked," rather than the hypothetical words "sonic" or "critical," should be a priority for the industrial, academic and regulatory communities involved with inhaler testing. ese changes would provide clarity for many in the community and enable quantitative testing to qualify flow control equipment, perhaps on an annual basis. Nomenclature A –cross-sectional area of converging nozzle (cm 2 ) c –speed of sound (cm/s) D 50 –aerodynamic particle size captured with 50% efficiency on a given impactor stage (µm) Ṁ –mass flow rate of air stream (g/sec) MW –molecular weight of air (gm/mole) P –absolute pressure of a flowing air stream (kPa) P 0 –absolute pressure of the source of the air flow (kPa) P 1 , P u –absolute pressure of the air flow stream upstream of the flow control valve (kPa) P 2 , P d –absolute pressure of the air flow stream down- stream of the flow control valve (kPa) r –ratio of the pressure in an air flow stream divided by the pressure at the source of the air flow (P/P 0 ) R –universal gas constant, 82.05 cm 3 -atm/ (Kelvin*mole) S –entropy (joule/Kelvin) T –absolute temperature (Kelvin) V –velocity of air flow stream (cm/s) X T –ratio of the pressure drop across the flow con- trol valve to the upstream pressure in Parker product literature Greek symbols g –ratio of the heat capacity per unit mass at constant pressure divided by the heat capacity per unit mass at constant volume r –gas density (g/cm 3 ) r 0 –gas density at the source of the air flow (g/cm 3 ) References 1. US Pharmacopeial Convention. United States Pharmacopeia 41/National Formulary 36 1S. 2021. Chapter <601>, Aerosols, Nasal Sprays, Metered- Dose Inhalers and Dry Powder Inhalers, USP, Rock- ville, MD, US. 2. European Directorate for Quality in Medicines and Healthcare (EDQM). 2024. European Pharma- apply to real flow control valves. e term "sonic" is shown to be needless by 1) the approximate nature of this thermodynamic analysis and 2) the fact that the practicing inhaler community does nothing to measure this velocity. e term "critical," arising simply from the calculus of the derivation of sonic conditions in the approximate thermodynamic anal- ysis, contributes only a hypothetical, mathemati- cal remark about the nature of the flow. For these reasons, we recommend that the terms "sonic" and "critical" are best dropped from written and oral communications in the inhaler testing community, including the regulatory community. Unfortunately, in the inhaler testing community, the term "critical" has taken on the meaning of "nec- essary to comply with standard testing protocols." at meaning has nothing to do with the science of the air flow and serves only to imply that the proper pressure ratio is necessary and sufficient for practi- cal testing. Our assertion is that in the absence of data like those in Figure 3, relying on P d /P u alone carries risk when in-use commercial equipment has not been tested for choked flow behavior, especially since the performance of commercial equipment can change over time. It would be a welcome simplification if the term "choked" would be used exclusively to specify the flow control for the testing of dry powder inhalers. is condition has the substantial advantage that it can be tested experimen- tally with equipment such as that in Figure 2. e pharmacopeial compendia have unintention- ally added to the lack of clarity in the terminology by highlighting a specific flow control valve whose manufacturer states will exhibit "choked" flow only when the pressure ratio across the valve (P d /P u ) is smaller than or equal to 0.17. Our data with this Parker valve 8FV12LN (Figure 3) show clearly that the air flow is choked when P d /P u is smaller than or equal to approximately 0.5, rather close to the value of 0.528 expected from the approximate ther- modynamic analysis. We attribute the seemingly anomalous pressure ratio value of 0.17 in the Parker product literature to the test protocol (ISA S75.02) that is stated in the Parker product literature. is test protocol requires a fully open flow control valve, quite different than the conditions of inhaler testing. We can hope for an explanatory publication of the data behind the manufacturer's product literature that would elucidate the reasons for the "choked" P d /P u value of 0.17. Absent these data, we recom- mend that references to the Parker choked flow con- dition and ISA S75.02 should be removed from the pharmacopeial compendia. Future work in this arena should focus on practical methods to document the "in-use" performance of flow control equipment in the testing of dry powder inhalers, possibly including solenoid valves as well as the flow control valves described herein. Also, chang-

